Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Faster global financial news!
Fosun Pharma: Luwomeitinib Tablets Receive Approval for Clinical Trials
25/02/2026 03:39
Complaint Report
Complaint Report
Fosun Pharma announced that its controlling subsidiary, Shanghai Fosun Pharma Industrial Development Co., Ltd., has received approval from the National Medical Products Administration (NMPA) to conduct clinical trials of Fumining in combination with anlotinib for patients with advanced non-small cell lung cancer harboring murine sarcoma virus (MSV) oncogene mutations. Fosun Pharma Industrial plans to conduct Phase II clinical trials of the drug in China once conditions are met.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
Scan to Download App
